Detalles de la búsqueda
1.
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Eur Heart J
; 43(13): 1307-1316, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617993
2.
Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study.
Catheter Cardiovasc Interv
; 96(1): 10-17, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402574
3.
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
Eur Heart J
; 38(42): 3124-3134, 2017 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020367
4.
First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial.
Catheter Cardiovasc Interv
; 87(7): E248-60, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26649651
5.
Quantitative Doppler for Estimation of Paravalvular Leakage after Transcatheter Aortic Valve Implantation.
J Heart Valve Dis
; 25(3): 289-295, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27989038
6.
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX study.
Catheter Cardiovasc Interv
; 85(2): 199-206, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24824456
7.
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.
Circulation
; 128(2): 141-51, 2013 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23766350
8.
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.
Eur Heart J
; 33(24): 3098-104, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23048195
9.
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
Eur Heart J
; 33(24): 3105-13, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23103663
10.
Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score".
Circulation
; 129(8): e355-6, 2014 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24566072
11.
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials.
Card Fail Rev
; 5(2): 99-105, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31179020
12.
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.
JACC Cardiovasc Interv
; 12(9): 805-819, 2019 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31072504
13.
Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document.
JACC Cardiovasc Interv
; 11(9): 823-832, 2018 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747912
14.
Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.
JACC Cardiovasc Interv
; 10(7): 658-666, 2017 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28385402
15.
Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study.
Eur Heart J Cardiovasc Imaging
; 18(1): 11-18, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26985077
16.
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.
JACC Cardiovasc Interv
; 9(16): 1667-76, 2016 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27539685
17.
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial.
EuroIntervention
; 12(11): e1336-e1342, 2016 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26465374
18.
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.
Cardiol J
; 23(6): 626-636, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27665852
19.
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention.
EuroIntervention
; 11(2): 171-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24531331
20.
Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II).
JACC Cardiovasc Interv
; 8(6): 824-833, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25999106